Test - Generic Drug Details
✉ Email this page to a colleague
Generic filers with tentative approvals for TEST
| Applicant | Application No. | Strength | Dosage Form |
| ⤷ Get Started Free | ⤷ Get Started Free | 30MG/1.5ML ACTUATION | SOLUTION, METERED;TRANSDERMAL |
| ⤷ Get Started Free | ⤷ Get Started Free | 750MG/3ML (250MG/ML) | INJECTABLE;INTRAMUSCULAR |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
US Patents and Regulatory Information for test
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | ANDRODERM | testosterone | FILM, EXTENDED RELEASE;TRANSDERMAL | 020489-004 | Oct 20, 2011 | DISCN | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Pfizer | DEPO-TESTOSTERONE | testosterone cypionate | INJECTABLE;INJECTION | 085635-003 | Approved Prior to Jan 1, 1982 | AO | RX | Yes | Yes | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | |||
| Marius | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | Y | ⤷ Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

